| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.08 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |